17.05.2011 • News

Teva CEO Shlomo Yanai Says Always Looking for More Acquisitions

Teva CEO Shlomo Yanai
Teva CEO Shlomo Yanai

Teva Pharmaceutical Industries is always looking for acquisitions and will move on other potential targets when it finds a strategic fit, its top executive said on Monday.

"We are scrutinizing constantly the opportunities and in due time we will move for further acquisitions when we find them a ... strategic fit," Teva CEO Shlomo Yanai said at a briefing in Tokyo.

Teva said on Monday that it would acquire 57% of privately held Taiyo Pharmaceutical Industry for $460 million in cash and would make an offer to buy the remaining shares of Japan's third-largest generic pharmaceutical company.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

Top-Feature

most read

Photo
News • Chemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.